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Abstract L1,3-N-Acetylglucosaminyltransferase-7 (L3Gn-T7)
has been identi¢ed as an anti-migration factor for a lung cancer
cell line but its enzymatic activity has not yet been character-
ized. Here we show that L3Gn-T7 e⁄ciently acts on keratan
sulfate-related glycans including GalL1C4(SO33C6)Glc-
NAcL1C3GalL1C4(SO33C6)GlcNAc (L2L2), while lacto-
N-tetraose and lacto-N-neo-tetraose were poor substrates.
Moreover, we found that among the other ¢ve L3Gn-Ts and i
antigen-producing L3Gn-T (iGn-T), L3Gn-T2 and iGn-T act
well on L2L2, although these speci¢c activities were lower
than those for a tetraantennary N-glycan. These results indicate
that L3Gn-T7 is the one that most e⁄ciently elongates L2L2
and may be involved in the biosynthesis of keratan sulfate.
. 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
L1,3-N-Acetylglucosaminyltransferase (L3Gn-T) catalyzes
the transfer of a GlcNAc residue from UDP-GlcNAc to the
C-3 position of non-reducing terminal Gal/GalNAc residues
by L-linkage. To date, six L3Gn-Ts (-T2 to -T7) and the i
antigen-producing L3Gn-T (iGn-T) have been cloned and in
most cases, their substrate speci¢cities have been extensively
studied [1^6]. L3Gn-T2 and iGn-T have strong poly-N-acetyl-
lactosamine-elongating activities [1,2], while L3Gn-T3 has a
core 1 extension activity that leads to the synthesis of a
6-sulfosialyl Lewis X or 6-sulfo-N-acetyllactosamine antigen,
MECA79, in lymph nodes [3]. L3Gn-T5 e⁄ciently acts on
lactosylceramide and plays a role in synthesizing lacto-series
glycolipids [4], and L3Gn-T6 synthesizes the core 3 structure,
GlcNAcL1! 3GalNAcK1C, which is one of the core units
in O-linked glycans [5]. In contrast, the nature of the enzy-
matic activity of L3Gn-T7 is unclear. Kataoka and Huh have
shown that transfection of lung cancer cells with an antisense
oligonucleotide for L3Gn-T7 enhances the motility of the
cells, which suggests that L3Gn-T7 may be involved in cancer
cell migration and invasion [6]. Moreover, these observations
imply that glycoconjugates synthesized by L3Gn-T7 may di-
rectly regulate cancer cell motility, invasion, and metastasis.
Therefore, it is important to characterize the enzymatic activ-
ity and substrate speci¢city of L3Gn-T7.
Keratan sulfate is a linear polymer of N-acetyllactosamine,
C3GalL1C4GlcNAcL1C, that bears a sulfate at the C-6
position of both monosaccharide moieties. Keratan sulfate is
present in the brain, the cornea, and cartilage, where it is
covalently conjugated to various proteins in the O- and
N-linked forms (reviewed in [7]). In the cornea, keratan sulfate
is linked to small leucine-rich core proteins, lumican, kerato-
kan, and mimecan, and contributes to maintaining the hydra-
tion and transparency of the cornea. Akama et al. showed
that GlcNAc6ST-5 (hCGn6ST or GST4L) bears GlcNAc
6-O-sulfotransferase activity and can synthesize keratan sul-
fate, and that several types of mutations in its gene cause
macular corneal dystrophy, an autosomal recessive disorder
that is characterized by corneal opaci¢cation [8^10]. Keratan
sulfate is proposed to be produced by the following sequential
reactions: 6-O-sulfation of the non-reducing terminal GlcNAc
by GlcNAc6ST-5 [10], L1,4-galactosylation of the GlcNAc
6-O-sulfate by L4GalT-IV as shown by us [11], L1,3-N-acetyl-
glucosaminylation of the Gal by L3Gn-T, and then 6-O-sulfa-
tion of internal Gal residues by Gal6ST(KS6ST) [12,13].
However, it remains unclear which of the L3Gn-Ts are in-
volved in the elongation of keratan sulfate.
In this study, we characterized the enzymatic activity of
L3Gn-T7 and found that L3Gn-T7 acts e⁄ciently on
GalL1C4(SO33C6)GlcNAcL1C3GalL1C4(SO
3
3C6)Glc-
NAc (L2L2) and GalL1C4(SO33C6)GlcNAcL1C3-
(SO33C6)GalL1C4(SO
3
3C6)GlcNAc (L2L4), both of which
correspond to a partial structure of keratan sulfate. This sug-
gests that L3Gn-T7 is associated with keratan sulfate biosyn-
thesis.
2. Materials and methods
2.1. Materials
UDP-[6-3H]GlcNAc (2.21 TBq/mmol) was purchased from Ameri-
can Radiolabeled Chemicals (St. Louis, MO, USA). GalNAcK1-O-p-
nitrophenyl (pNP) and FucK1C3(GalL1C4)GlcNAcL1C3GalL1C
4Glc (lacto-N-fucopentaose-III, LNF-III) were purchased from Funa-
koshi (Tokyo, Japan). Bovine milk L1,4-galactosyltransferase, UDP-
Gal, and UDP-GlcNAc were purchased from Sigma (St. Louis, MO,
USA). GalL1C3GlcNAcL1C3GalL1C4Glc (lacto-N-tetraose, ab-
breviated to LNT) and GalL1C4GlcNAcL1C3GalL1C4Glc(lacto-
N-neo-tetraose, abbreviated to LNnT) were prepared from human
milk [14]. Ricinus communis agglutinin-I (RCA-I)-agarose (4 mg/ml
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gel) was obtained from Hohnen Oil (Tokyo, Japan). Psathyrella velu-
tina lectin (PVL) was prepared according to the method described by
Kochibe and Matta [15], and the lectin was conjugated to CNBr-ac-
tivated Sepharose 4B (Amersham Pharmacia Biotech) according to
the manufacturer’s instructions. GalL1C4GlcNAcL1C2ManK1C3
(GalL1C4GlcNAcL1C2ManK1C6)ManL1C4GlcNAc (biGP) and
GalL1C4GlcNAcL1C2(GalL1C4GlcNAcL1C4)ManK1C3[GalL1C
4GlcNAcL1C2(GalL1C4GlcNAcL1C6)ManK1C6]ManL1C4Glc-
NAc (tetraGP) were obtained from the urine of GM1 gangliosidosis
patients [16]. Streptococcus 6646K L-galactosidase and keratanase II
(Bacillus sp.) were purchased from Seikagaku (Tokyo, Japan). L2L2,
L2L4, and SO33C6GalL1C4(SO
3
3C6)GlcNAcL1C3(SO
3
3C6)-
GalL1C4(SO33C6)GlcNAc (L4L4) were kindly donated by Seikaga-
ku. Authentic [3H]GlcNAcL1C3GalL1C4GlcNAcL1C3GalL1C
4Glc was prepared using the crude membrane of L3Gn-T2-transfected
COS-7 cells described below.
2.2. cDNA cloning of L3Gn-Ts
The cDNAs encoding the full open reading frames of L3Gn-T3,
-T6, and -T7 were ampli¢ed by polymerase chain reaction from BD
Marathon-Ready human colon cDNA (Clontech, Palo Alto, CA,
USA). In the case of L3Gn-T2, -T4, -T5, and iGn-T, the SuperScript
human brain cDNA library (Invitrogen) was used as the template.
The oligonucleotide primers used were 5P-tttaagcttGAGAAAT-
GAGTGTTGGA-3P (forward primer for L3Gn-T2), 5P-ttttctagaAC-
ACAACATGGGAAC-3P (reverse primer for L3Gn-T2), 5P-
tttaagcttGGCCAGGATGAAGTATC-3P (forward primer for L3Gn-
T3), 5P-ttttctagaGGAAGGTGTCGCCC-3P (reverse primer for L3Gn-
T3), 5P-tttaagcttCCAGCTGCCGTTCATG-3P (forward primer for
L3Gn-T4), 5P-ttttctagaGTCCACTCTCAGGCT-3P (reverse primer
for L3Gn-T4), 5P-tttaagcttGAGTGGATATGAGA-3P (forward prim-
er for L3Gn-T5), 5P-ttttctagaGGTTTGACTCAGTGACA-3P (reverse
primer for L3Gn-T5), 5P-tttaagcttATGGCTTTTCCCTGCCG-3P (for-
ward primer for L3Gn-T6), 5P-ttttctagaCCTCAGGAGACCCGGTG-
3P (reverse primer for L3Gn-T6), 5P-tttaagcttCCGCCATGTCGCT-
GTG-3P (forward primer for L3Gn-T7), 5P-ttttctagaGCACCTGGA-
GCT-3P (reverse primer for L3Gn-T7), 5P-tttaagcttGGCGTAGTCT-
GTGGCC-3P (forward primer for iGn-T), and 5P-ttttctagaGCCAAG-
AGGCTGACT-3P (reverse primer for iGn-T). The sequences shown
by lowercase letters reveal appropriate restriction sites. The ampli¢ed
cDNAs were digested with HindIII and XbaI and cloned into
pcDNA3 (Invitrogen). The resulting plasmids were sequenced using
an Applied Biosystems Prism 310 Genetic Analyzer (PE Biosystems).
The nucleic acid sequences of cloned cDNAs for L3Gn-T2, -T3, -T4,
-T5, -T6, and -T7, and iGn-T were equal to those for the accession
numbers AB049584, AB049585, AB049586, AB045278, AB073740,
AF502430, and AF029893, respectively. The transient expression
of the L3Gn-Ts in COS-7 cells and the preparation of their crude
membrane fractions were performed as described previously [17].
The crude membrane fractions were used to examine the enzymatic
activities.
2.3. Assay of L3Gn-T activity
Twenty Wl of reaction mixtures consisting of 50 mM HEPES-NaOH
(pH 7.2), 10 mM MnCl2, 0.5% (w/v) Triton X-100, 1 mM acceptor
substrate, 2.5 WM UDP-[3H]GlcNAc (6.7U106 dpm), 30 WM UDP-
GlcNAc, 0.1 M GlcNAc, 1 mM AMP, and appropriately diluted
membrane fractions were incubated at 37‡C for 3 h. The 3H-labeled
products were puri¢ed by paper electrophoresis (pyridine:acetic acid:
water, 3:1:387, pH 5.4) and then paper chromatography (pyri-
dine:ethyl acetate:acetic acid:water, 5:5:1:3). In the case of L2L4
and L4L4, mild acid hydrolysis (0.01 N HCl, 100‡C, 10 min) was
performed to destroy residual UDP-[3H]GlcNAc before paper electro-
phoresis since [3H]GlcNAcCL2L4 andCL4L4 cannot be separated
from UDP-[3H]GlcNAc by paper electrophoresis. After drying, the
paper was monitored for radioactivity with a radiochromatogram
scanner and the 3H-labeled products were extracted with water and
counted. In the case of GalNAcK-O-pNP and Lac-O-pNP, the ex-
tracts were further applied onto a C18 Sep-Pak column (Waters, Mil-
ford, MA, USA) and the 3H-labeled products were eluted with 50%
MeOH and counted. The membrane fraction derived from empty
pcDNA3-transfected COS-7 cells was used to control for intrinsic
L3Gn-T activities. The protein concentrations of the membrane frac-
tions were estimated using the Bio-Rad Protein Assay dye reagent
with bovine serum albumin as a standard.
3. Results and discussion
3.1. Characterization of the 3H-labeled compound produced by
L3Gn-T7
We investigated the enzymatic activity of L3Gn-T7 by using
the crude membrane fraction derived from L3Gn-T7-trans-
fected COS-7 cells. When the reaction mixture containing
L2L2 as the acceptor substrate was subjected to paper elec-
trophoresis, a radioactive peak (fraction I) appeared (Fig.
1A). Other peaks (0, 6.6, and 9.8 cm) were also present
when the reaction had been performed without L2L2 (data
not shown) and thus are not L2L2-derived compounds. Frac-
tion I was extracted with water and subjected to linkage anal-
ysis of [3H]GlcNAc. After digesting fraction I with keratanase
II, an endo-L-N-acetylglucosaminidase [18] that acts on the
6-O-sulfated GlcNAc in keratan sulfate, a radioactive peak
appeared at a less quickly migrating position (Fig. 1B), which
indicates that the [3H]GlcNAc in fraction I was indeed incor-
porated into L2L2. However, fraction I was refractory to
Streptococcus 6646K L-galactosidase digestion. Furthermore,
fraction I could bind to a PVL-Sepharose column and was
eluted with 0.3 M GlcNAc, while in contrast it £owed through
an RCA-I-agarose column. Since PVL and RCA-I bind to the
non-reducing terminal L-GlcNAc and GalL1C4(RC6)Glc-
NAcL1C, respectively [15,19], it appears that the
[3H]GlcNAc is attached to the distal Gal residue of L2L2.
Fraction I was then galactosylated by bovine milk L1,4-gal-
actosyltransferase. The product bound to a RCA-I-agarose
column but not to a PVL column, which indicates that the
Fig. 1. Analysis of the [3H]GlcNAc linkages of [3H]GlcNAcCL2L2
synthesized by human L3Gn-T7 by paper electrophoresis at pH 5.4.
A: The mixture after the enzymatic reaction. B: Bacillus sp. kerata-
nase II digests of fraction I. C: The Smith degradation product of
[3H]L2L2 which was provided previously [11]. D: The periodate oxi-
dation and the Smith degradation product of GalL1C4[3H]Glc-
NAcCL2L2. Arrows a^d indicate the positions of bromophenol
blue, UDP-[3H]GlcNAc, [3H]L2L2, and GalL1C4[3H]GlcNAcC
L2L2, respectively.
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C-4 position of the [3H]GlcNAc was completely L-galactosy-
lated. The galactosylated fraction I was subjected to periodate
oxidation and Smith degradation [17,20]. If [3H]GlcNAc binds
to the C-3 position of the distal Gal, [3H]GlcNAcL1C3GalL1
C4(SO33C6)GlcNAcL1C3GalL1C4(SO
3
3C6)GlcNAc-ol
and its partially desulfated derivatives should be produced by
the treatment. The partial 6-O-desulfation caused by Smith
degradation (0.05 N H2SO4, 80‡C, 1 h) was con¢rmed by
using [3H]L2L2 [11] (Fig. 1C). In addition to a peak for
[3H]L2L2 (10.3 cm), two peaks for mono-sulfated (5.5 cm)
and non-sulfated (origin) [3H]L2L2 appeared. On the other
hand, if [3H]GlcNAc binds to the C-2, C-4, or C-6 position
of the distal Gal, [3H]GlcNAcL1-O-glyceraldehyde (C-2),
[3H]GlcNAcL1-O-glycerol (C-6), or [3H]GlcNAcL1-O-threitol
(C-4) should be produced. After the oxidation and Smith deg-
radation, the reaction mixture was subjected to paper electro-
phoresis (Fig. 1D). Three radioactive peaks (II, III, and IV)
were detected. Peak IV migrated to the same position as frac-
tion I on paper electrophoresis. This position was between
[3H]L2L2 (di-sulfated tetraose) (arrow c) and GalL1C
4[3H]GlcNAcCL2L2 (di-sulfated hexaose) (arrow d), sug-
gesting that peak IV consisted of pentaose with two sulfate
residues. Peak IV migrated on silica gel thin layer chromatog-
raphy (pyridine:ethyl acetate:acetic acid:water, 5:5:1:3) to
the same position (Rf value, 0.20) as [3H]GlcNAcCL2L2-ol
which was prepared by NaBH4 reduction of fraction I.
These results indicated that peak IV is [3H]GlcNAcL1C
3GalL1C4(SO33C6)GlcNAcL1C3GalL1C4(SO
3
3C6)Glc-
NAc-ol. When peak II was applied to thin layer chromatog-
raphy, it moved to the same position as authentic
[3H]GlcNAcL1C3GalL1C4GlcNAcL1C3GalL1C4Glc,
which indicates that it is a non-sulfated form. The migration
position of peak III suggests it is the mono-sulfated form.
These results reveal that [3H]GlcNAc was attached to the
C-3 position of the distal Gal of L2L2 and that L3Gn-T7
indeed has a L1,3-N-acetylglucosaminyltransferase activity.
The speci¢c activities of the crude membrane derived from
L3Gn-T7-transfected COS-7 cells and empty-pcDNA3-trans-
fected COS-7 cells were 4.87 and 1.08 pmol/min/mg protein,
respectively. We estimated the speci¢c activity of exogenous
L3Gn-T7 as 3.79 pmol/min/mg protein by subtraction.
3.2. Enzymological properties of L3Gn-T7
The optimal pH of L3Gn-T7 was at 6.5^7.0. The addition
of 10 mM EDTA to the reaction mixture instead of MnCl2
decreased the enzymatic activity to 12%. Addition of MgCl2
and CaCl2 (10 mM) resulted in one-third of the activity that
was observed in the presence of MnCl2.
The substrate speci¢city of L3Gn-T7 is shown in Table 1.
The keratan sulfate-related sulfated glycans L2L2 and L2L4
were much better substrates than LNnT, which indicates that
L3Gn-T7 recognizes internal 6-O-sulfated N-acetylglucos-
amine moieties. However, 6-O-sulfation of the non-reducing
terminal Gal hampered the enzymatic activity since L4L4 was
a poor substrate, in contrast to L2L2 and L2L4. Moreover,
L3Gn-T7 can act on tetraGP.
The kinetic parameters for L2L2, L2L4, and tetraGP are
summarized in Table 2. The Vmax/Km values for L2L2 and
L2L4 were higher than that for tetraGP, which indicates
that L3Gn-T7 acts more e⁄ciently on L2L2 and L2L4 than
on tetraGP.
3.3. Substrate speci¢cities of the seven L3Gn-Ts
Next, to assess whether L2L2 and L2L4 are good acceptors
for other L3Gn-Ts as well, we transfected COS-7 cells with
expression vectors containing cDNAs encoding each L3Gn-T
and prepared crude membrane fractions, which served as the
enzyme sources. As shown in Table 3, L3Gn-T2 and iGn-T
act on L2L2 but L2L4 and L4L4 are not substrates for L3Gn-
Ts other than L3Gn-T7. TetraGP was a good substrate for all
the L3Gn-Ts, and L3Gn-T2 and iGn-T preferred tetraGP to
L2L2, unlike the case of L3Gn-T7. These observations indi-
cate that L3Gn-T7 is the most e⁄cient enzyme for L2L2 and
L2L4 of the L3Gn-Ts that have been identi¢ed to date.
3.4. General discussion
Based on these studies, we propose keratan sulfate is bio-
synthesized by the pathway shown in Fig. 2. First,
GlcNAc6ST-5 transfers a sulfate to the C-6 position of the
non-reducing terminal GlcNAc [10]. Next, galactosylation is
performed by L4GalT-IV, which is the only L4GalT that is
highly speci¢c for GlcNAc 6-O-sulfate residues [11]. As shown
in this study, GalL1C4(SO33C6)GlcNAc can be elongated
by L3Gn-T7. Finally, internal Gal residues are 6-O-sulfated
Table 1
Substrate speci¢city of L3Gn-T7
Substratea Relative activity (%)
GalL1C4(SO33C6)GlcNAcL1C3GalL1C4(SO
3
3C6)GlcNAc (L2L2) 100
b
GalL1C4(SO33C6)GlcNAcL1C3(SO
3
3C6)GalL1C4(SO
3
3C6)GlcNAc (L2L4) 72
SO33C6GalL1C4(SO
3
3C6)GlcNAcL1C3(SO
3
3C6)GalL1C4(SO
3
3C6)GlcNAc (L4L4) 3
Gal4WGlcNAc4WMan3WGlcNAc (tetraGP) 40
Gal2WGlcNAc2WMan3WGlcNAc (biGP) 10
GalL1C4GlcNAcL1C3GalL1C4Glc (LNnT) 5
GalL1C3GlcNAcL1C3GalL1C4Glc (LNT) 6 1
GalNAcK-O-pNP 6 1
GalL1C4GlcL1-O-pNP (Lac-O-pNP) 3
GalL1C4(FucK1C3)GlcNAcL1C3GalL1C4Glc (LNF-III) 6 1
aThe concentrations of the substrates were 1 mM.
bThe relative values are taken from the value of L2L2 as 100. The enzymatic activities were the means of four independent experiments (S.D.,
less than 5%).
Table 2
Kinetic analysis of L3Gn-T7 for several oligosaccharides
Substrate L2L2 L2L4 TetraGP
Km (mM) 0.36 0.10 0.23
Vmax (pmol/min/mg protein) 16.7 6.5 2.9
Vmax/Km 46 65 13
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by Gal6ST [12,13]. It may thus be possible to synthesize ker-
atan sulfate in vitro by using an enzyme mixture composed of
GlcNAc6ST-5, L4GalT-IV, L3Gn-T7, and Gal6ST and a sub-
strate mixture that includes an appropriate initiator acceptor
glycan. Such in vitro synthesis of keratan sulfate is currently
in progress.
Kataoka and Huh have shown that lung cancer KLN205-
MUC1 cells become more migratory and invasive when they
are transfected with the antisense oligonucleotide for L3Gn-T7
[6]. These observations suggest that glycoconjugates synthe-
sized by L3Gn-T7 may serve to diminish the motility of the
cancer cells. Our observations suggest that a probable candi-
date glycoconjugate may be keratan sulfate. Supporting this is
that it has been shown that the expression of keratan sulfate is
down-regulated in migrating corneal endothelial cells [21] and
in ¢broblasts that have been transdi¡erentiated from stromal
keratocytes [22], as compared to the respective quiescent cells.
Moreover, exogenous keratan sulfate inhibits matrix metallo-
proteinase-2 activation in corneal and skin explant cultures
[23]. It is thus interesting to determine whether KLN205-
MUC1 cells express keratan sulfate and whether this com-
pound functions as an anti-migration factor.
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aThe concentrations of the substrates were 1 mM.
bNot determined.
Fig. 2. Proposed scheme for the biosynthesis of keratan sulfate.
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